首页> 外文期刊>Frontiers in Neuropharmacology >Hydroxysafflor Yellow A and Anhydrosafflor Yellow B Protect Against Cerebral Ischemia/Reperfusion Injury by Attenuating Oxidative Stress and Apoptosis via the Silent Information Regulator 1 Signaling Pathway
【24h】

Hydroxysafflor Yellow A and Anhydrosafflor Yellow B Protect Against Cerebral Ischemia/Reperfusion Injury by Attenuating Oxidative Stress and Apoptosis via the Silent Information Regulator 1 Signaling Pathway

机译:通过通过静音信息调节器1信号通路衰减氧化应激和凋亡,羟基烷烷烃黄色A和Anhydrosafflor黄B防止脑缺血/再灌注损伤

获取原文
           

摘要

Hydroxysafflor yellow A (HSYA) and anhydrosafflor yellow B (AHSYB) are the main watersoluble compounds in Carthamus tinctorius L. However, studies on the effect of AHSYB on cerebral ischemia/reperfusion (I/R) injury and the therapeutic effect of HSYA by regulating silent information regulator 1 (SIRT1) pathway remain obscure. In this study, we investigated whether the neuroprotective effects of HSYA and AHSYB on oxygenglucose deprivation/reoxygenation in primary-cultured hippocampal neuronal cells and the middle cerebral artery occlusion and reperfusion model in rats are associated with the regulation of the SIRT1 pathway. In vitro, HSYA and AHSYB increased cell viability, depressed oxidation properties, and reduced neuronal cell apoptosis. In vivo results showed that HSYA and AHSYB effectively reduced infarct volume, improved neurological function, suppressed apoptosis, and decreased the oxidative stress reaction. Besides, RT-PCR and Western blot analysis showed that HSYA and AHSYB increased the mRNA and protein expressions of the main factors in the SIRT1 pathway, including SIRT1, forkhead box O (FOXO) 1, and peroxisome proliferator–activated receptor coactivator 1α (PGC1α), decreased the expression of Bax, and increased the expression of Bcl-2. The results from immunohistochemistry also showed that the expressions of SIRT1, FOXO1, and PGC1α were increased after treatment with HSYA and AHSYB. Furthermore, the neuroprotective effects of HSYA and AHSYB were abolished by EX527 (SIRT1–specific inhibitor). These results indicated that HSYA and AHSYB should be developed into potential drugs for treating cerebral I/R injury via the SIRT1 pathway. Although HSYA and AHSYB have different chemical structures, both of them exert similar neuroprotective properties against I/R injury in vitro and in vivo, which means that AHSYB is also a nonnegligible component in safflower.
机译:羟烷烷烃黄色A(HSYA)和Anhydrosafflor黄B(AHSYB)是迦太福氏菌的主要水溶化合物。然而,通过调节研究AHSYB对脑缺血/再灌注(I / R)损伤的影响及其对HSYA的治疗效果静音信息调节器1(SIRT1)路径仍然模糊不清。在这项研究中,我们研究了HSYA和AHSYB对初级培养的海马神经元细胞和大鼠中脑动脉闭塞和再灌注模型的oxygenglucose剥夺/释放和再灌注模型的神经保护作用是否与SIRT1途径的调节有关。体外,HSYA和AHSYB增加细胞活力,抑制氧化性能和降低的神经元细胞凋亡。体内结果表明,HSYA和AHSYB有效地降低了梗塞体积,改善神经功能,抑制细胞凋亡,降低氧化应激反应。此外,RT-PCR和Western印迹分析表明,HSYA和AHSYB增加了SIRT1途径中主要因素的mRNA和蛋白质表达,包括SIRT1,FOXHEAD盒O(FOXO)1和过氧化物激素激活的受体共粘膜1α(PGC1α ),降低了Bax的表达,并增加了Bcl-2的表达。免疫组织化学的结果还表明,用HSYA和AHSYB治疗后,SIRT1,FOXO1和PGC1α的表达增加。此外,EX527(SIRT1特异性抑制剂)废除了HSYA和AHSYB的神经保护作用。这些结果表明,HSSYA和AHSYB应开发成通过SIRT1途径治疗脑I / R损伤的潜在药物。虽然HSYA和AHSYB具有不同的化学结构,但它们的两者都施加了对体外和体内I / R损伤的类似神经保护性能,这意味着AHSYB也是红旱麻中的非阻载成分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号